These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16967353)

  • 1. [Aspirin resistance theory].
    Porosińska A; Pierzchała K
    Neurol Neurochir Pol; 2006; 40(4):313-9. PubMed ID: 16967353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclooxigenase-1 gene polymorphism and aspirin resistance].
    Bondar' TN; Kravchenko NA
    Tsitol Genet; 2012; 46(4):66-72. PubMed ID: 23074965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aspirin resistance: position paper of the working group on aspirin resistance of the international society on thrombosis and haemostasis].
    Boskholov BP
    Kardiologiia; 2005; 45(7):75-6. PubMed ID: 16091668
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aspirin resistance].
    Yilmaz MB; Balbay Y; Korkmaz S
    Anadolu Kardiyol Derg; 2004 Mar; 4(1):59-62. PubMed ID: 15033621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acetylsalicylic acid in the treatment of ischemic cerebrovascular disorders].
    Caneschi S; Bonaventi C; Finzi F; Tito P
    Minerva Med; 1986 Jun; 77(27):1299-308. PubMed ID: 3523307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin as an antithrombotic drug: from the aggregometer to clinical trials.
    de Gaetano G
    Verh K Acad Geneeskd Belg; 1990; 52(6):459-71; discussion 471-3. PubMed ID: 2150736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin.
    Undas A; Placzkiewicz-Jankowska E; Zieliński L; Tracz W
    Thromb Haemost; 2007 Jun; 97(6):1056-8. PubMed ID: 17549314
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks.
    Grundmann K; Jaschonek K; Kleine B; Dichgans J; Topka H
    J Neurol; 2003 Jan; 250(1):63-6. PubMed ID: 12527994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terms and conditions: semantic complexity and aspirin resistance.
    Hennekens CH; Schror K; Weisman S; FitzGerald GA
    Circulation; 2004 Sep; 110(12):1706-8. PubMed ID: 15381661
    [No Abstract]   [Full Text] [Related]  

  • 18. Can platelet function tests predict the clinical efficacy of aspirin?
    Haubelt H; Anders C; Hellstern P
    Semin Thromb Hemost; 2005; 31(4):404-10. PubMed ID: 16149017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet effect of aspirin in patients with cerebrovascular disease.
    Alberts MJ; Bergman DL; Molner E; Jovanovic BD; Ushiwata I; Teruya J
    Stroke; 2004 Jan; 35(1):175-8. PubMed ID: 14671242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.